Document is current
Any future updates will be listed below
-
Authors
Song, Bing https://orcid.org/0000-0002-9905-410X
Wang, Kaiwen
Na, Saiyang https://orcid.org/0000-0002-2662-5063
Yao, Jia
Fattah, Farjana J.
Martin, Alexandra L.
von Itzstein, Mitchell S.
Yang, Donghan M.
Liu, Jialiang
Xue, Yaming
Liang, Chaoying
Guo, Yuzhi
Raman, Indu
Zhu, Chengsong https://orcid.org/0000-0001-8872-9450
Dowell, Jonathan E.
Homsi, Jade
Rashdan, Sawsan
Yang, Shengjie
Gwin, Mary E.
Wu, Tuoqi https://orcid.org/0000-0002-4003-1034
Hsiehchen, David
Gloria-McCutchen, Yvonne
Lu, Catherine Pei-ju
Raj, Prithvi
Bai, Xiao-chen https://orcid.org/0000-0002-4234-5686
Wang, Jun
Conejo-Garcia, Jose https://orcid.org/0000-0001-6431-4074
Xie, Yang https://orcid.org/0000-0001-9456-1762
Huang, Junzhou https://orcid.org/0000-0002-9548-1227
Gerber, David E. https://orcid.org/0000-0002-7812-6741
Wang, Tao https://orcid.org/0000-0002-4355-149X
-
Funding
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RP190208)
Cancer Prevention and Research Institute of Texas (RP230363)
Cancer Prevention and Research Institute of Texas (RP230363)
U.S. Department of Health & Human Services | National Institutes of Health (R38HL150214)
U.S. Department of Health & Human Services | National Institutes of Health (1U01AI156189)
American Cancer Society (MRAT-18-114-01-LIB)
V Foundation Robin Roberts Cancer Survivorship
- License Information
-
More Information
Article History
Received: 15 July 2024
Accepted: 19 May 2025
First Online: 27 June 2025
Competing interests
: T.W. reports personal fees from Merck. D.G. has received research funding from Astra-Zeneca, BerGenBio, Karyopharm and Novocure, has stock ownership in Gilead, Medtronic and Walgreens, holds consulting or advisory board positions in Astra-Zeneca, Catalyst Pharmaceuticals, Daiichi-Sankyo, Elevation Oncology, Janssen Scientific Affairs, Jazz Pharmaceuticals, Regeneron Pharmaceuticals and Sanofi and is the cofounder and chief scientific officer of OncoSeer Diagnostics. The remaining authors declare no competing interests.
Free to read: This content has been made available to all.
